| 000 | 01611 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518070802.0 | ||
| 264 | 0 | _c20210119 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a2045-7634 | ||
| 024 | 7 |
_a10.1002/cam4.2679 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMao, Weipu | |
| 245 | 0 | 0 |
_aTreatment of advanced gallbladder cancer: A SEER-based study. _h[electronic resource] |
| 260 |
_bCancer medicine _c01 2020 |
||
| 300 |
_a141-150 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xstatistics & numerical data |
| 650 | 0 | 4 |
_aCholecystectomy _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGallbladder _xpathology |
| 650 | 0 | 4 |
_aGallbladder Neoplasms _xmortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPalliative Care _xstatistics & numerical data |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSEER Program _xstatistics & numerical data |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aDeng, Fang | |
| 700 | 1 | _aWang, Dongyan | |
| 700 | 1 | _aGao, Li | |
| 700 | 1 | _aShi, Xiuquan | |
| 773 | 0 |
_tCancer medicine _gvol. 9 _gno. 1 _gp. 141-150 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cam4.2679 _zAvailable from publisher's website |
| 999 |
_c30307440 _d30307440 |
||